ES511982A0 - "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis". - Google Patents

"procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".

Info

Publication number
ES511982A0
ES511982A0 ES511982A ES511982A ES511982A0 ES 511982 A0 ES511982 A0 ES 511982A0 ES 511982 A ES511982 A ES 511982A ES 511982 A ES511982 A ES 511982A ES 511982 A0 ES511982 A0 ES 511982A0
Authority
ES
Spain
Prior art keywords
plasminogen
procedure
preparation
practically free
hepatitis viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511982A
Other languages
English (en)
Other versions
ES8303442A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES8303442A1 publication Critical patent/ES8303442A1/es
Publication of ES511982A0 publication Critical patent/ES511982A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES511982A 1981-05-14 1982-05-07 "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis". Granted ES511982A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813119157 DE3119157A1 (de) 1981-05-14 1981-05-14 Verfahren zur herstellung von und danach hergestelltes plasminogen

Publications (2)

Publication Number Publication Date
ES8303442A1 ES8303442A1 (es) 1983-02-01
ES511982A0 true ES511982A0 (es) 1983-02-01

Family

ID=6132282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511982A Granted ES511982A0 (es) 1981-05-14 1982-05-07 "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".

Country Status (11)

Country Link
US (1) US4442213A (es)
EP (1) EP0065256B1 (es)
JP (1) JPS57193418A (es)
AT (1) ATE21824T1 (es)
AU (1) AU547139B2 (es)
CA (1) CA1187411A (es)
DE (2) DE3119157A1 (es)
ES (1) ES511982A0 (es)
IL (1) IL65752A (es)
MX (1) MX7033E (es)
NZ (1) NZ200589A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604358A (en) * 1983-04-14 1986-08-05 Armour Pharmaceutical Company Preparation of pasteurized human plasminogen
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
US4699525A (en) * 1985-07-18 1987-10-13 Ebara Corporation Thrust bearing
JPS62153224A (ja) * 1985-12-27 1987-07-08 Green Cross Corp:The プラスミノゲン製剤
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
WO1997001631A1 (fr) * 1995-06-26 1997-01-16 Daiichi Pure Chemicals Co., Ltd. Solution stable de plasmine
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
MX2010013282A (es) * 2008-06-04 2010-12-21 Talecris Biotherapeutics Inc Composicion, metodo y kit para la preparacion de plasmina.
EP2403865B9 (en) 2009-03-03 2015-12-09 Grifols Therapeutics Inc. Methods for preparing plasminogen
CN107249622B (zh) 2014-12-19 2021-08-03 普罗米蒂克生物治疗有限公司 包含纤溶酶原的药物组合物和其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2347048A2 (fr) * 1976-04-07 1977-11-04 Choay Sa Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
JPS56106594A (en) * 1980-01-25 1981-08-24 Green Cross Corp:The Stabilizing method of plasminogen
GB2068002B (en) * 1980-01-25 1983-06-29 Green Cross Corp Plasminogen preparation and their production
JPS5716824A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Plasminogen pharmaceutical and stabilizing method thereof
FR2504921A1 (fr) * 1981-04-30 1982-11-05 Choay Sa Medicament nouveau constitue par un complexe aprotinine-plasmine et procede de preparation de ce nouveau complexe

Also Published As

Publication number Publication date
IL65752A0 (en) 1982-08-31
ATE21824T1 (de) 1986-09-15
EP0065256A3 (en) 1984-01-18
NZ200589A (en) 1985-04-30
AU8366182A (en) 1982-11-18
JPS57193418A (en) 1982-11-27
EP0065256B1 (de) 1986-09-03
CA1187411A (en) 1985-05-21
DE3119157A1 (de) 1982-12-09
EP0065256A2 (de) 1982-11-24
MX7033E (es) 1987-03-03
AU547139B2 (en) 1985-10-10
ES8303442A1 (es) 1983-02-01
JPH0366292B2 (es) 1991-10-16
US4442213A (en) 1984-04-10
DE3272987D1 (en) 1986-10-09
IL65752A (en) 1985-05-31

Similar Documents

Publication Publication Date Title
ES511982A0 (es) "procedimiento para la preparacion de plasminogeno practicamente exento de virus de hepatitis".
BR8207582A (pt) Processo para producao de novas composicoes de enzima para coagulacao sang"uinea
NO832630L (no) Trifenylimidazolyloxyalkansyrer og deres derivater, deres fremstilling og deres anvendelse i preparater
DE3166201D1 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ii and vii
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
DK272287A (da) Fremgangsmaade til inaktivering af formeringsdygtige, filtrerbare sygdomsfremkaldere
Morikawa et al. Studies on aspirin esterase of human serum
KR870003790A (ko) 인간 트롬빈제제의 가열처리방법
AU568849B2 (en) Inactivation of viruses in virus containing protein samples
NO163629C (no) Konsentrert, vandig toeymykningsmiddelblanding og fremgangsmaate ved fremstilling derav.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
FI843436A (fi) Foerfarande foer framstaellning av 2-oxo-karbonsyrareduktas och dess anvaendning.
ES2059323T3 (es) Procedimiento para la produccion de una preparacion de inmunoglobulina pasteurizada.
SE8600987L (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
JPS5261165A (en) Method of removing slime
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
JPS5238009A (en) Method for the manufacture of hige- activity prophylactic and therapeu tic agent for viral infections
JPS52117489A (en) L-asparaginase-embedded fibrin and heat stabilization thereof
Shattock et al. Process for obtaining delta antigen of hepatitis D virus and use of said antigen as a diagnostic agent.
ATE5406T1 (de) 2-methyl-3-(2,4,6-trijod-3-(1morpholino[thylidenamino)-benzamido)propionitril, verfahren zu dessen herstellung und dessen verwendung als zwischenprodukt.
DE3586795D1 (de) Absorptionsverbesserer fuer proteine.
RO64282A2 (fr) Methode pour la determination d'acide 2,4-dichlorphenoxy acetique des produites phytofarmaceutiques en base d'acide 2,4-diclorphenoxycetique et 3,6-dichlore-2-metoxybenzoique

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010402